Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · IEX Real-Time Price · USD
15.00
-0.06 (-0.40%)
At close: Jun 17, 2024, 4:00 PM
14.82
-0.18 (-1.20%)
After-hours: Jun 17, 2024, 7:46 PM EDT
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 167 employees on December 31, 2023. The number of employees increased by 85 or 103.66% compared to the previous year.
Employees
167
Change (1Y)
85
Growth (1Y)
103.66%
Revenue / Employee
$2,463,156
Profits / Employee
$389,922
Market Cap
1.77B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 167 | 85 | 103.66% |
Dec 31, 2022 | 82 | 6 | 7.89% |
Dec 31, 2021 | 76 | 2 | 2.70% |
Dec 31, 2020 | 74 | -2 | -2.63% |
Dec 31, 2019 | 76 | 25 | 49.02% |
Dec 31, 2018 | 51 | 30 | 142.86% |
Dec 31, 2017 | 21 | 3 | 16.67% |
Dec 31, 2016 | 18 | -5 | -21.74% |
Dec 31, 2015 | 23 | 11 | 91.67% |
Dec 31, 2014 | 12 | 5 | 71.43% |
Dec 31, 2013 | 7 | 1 | 16.67% |
Dec 31, 2012 | 6 | 0 | - |
Dec 31, 2011 | 6 | 0 | - |
Dec 31, 2010 | 6 | 0 | - |
Dec 31, 2009 | 6 | -1 | -14.29% |
Dec 31, 2008 | 7 | 0 | - |
Dec 31, 2007 | 7 | 2 | 40.00% |
Dec 31, 2006 | 5 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Addus HomeCare | 34,846 |
Teladoc Health | 5,600 |
Zai Lab | 2,175 |
NeoGenomics | 2,100 |
LeMaitre Vascular | 630 |
Arvinas | 445 |
Syndax Pharmaceuticals | 184 |
CPRX News
- 18 days ago - Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE® - GlobeNewsWire
- 20 days ago - Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024 - GlobeNewsWire
- 5 weeks ago - Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 2 months ago - Jim Cramer recommends five small-cap health-care stocks - CNBC
- 2 months ago - Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium - GlobeNewsWire